OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 19, 2013
Semi-automatic technology aids egg-based influenza vaccine production in smaller facility footprints.
June 14, 2013
PSL has developed a microsphere refiner for microsphere formulation, from small scale processes to commercial production.
June 12, 2013
Aseptic connectors provide the flexibility and robustness needed for modern parenteral manufacturing operations.
The lipid-based method provides a tool for delivery of highly potent, poorly soluble, and unstable APIs. And new in-process capsule printing and shell technologies expand softgels’ applications further.
Conjugated vaccines are meeting the need for longer-lasting immune responses, but the production process is complex, and manufacturers are looking for simpler solutions.
June 11, 2013
EMA's revised guideline on biosimilars containing biotechnology-derived proteins is published for public consultation.
June 10, 2013
Facility will use mammalian cell-culture technology and be ready for operations by 2016.
June 05, 2013
The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
June 02, 2013
The Fluid Air Tablet Coating System consists of a modular air atomizing manifold, liquid-delivery skid, and Batch Architect process controls.
Models and modeling software gain a foothold in solid-dosage manufacturing process design.